About this episode

The episode discusses the use and switching of biosimilars in clinical practice, including communication tips and operational considerations.

Listen in as we discuss considerations, challenges, and strategies related to the use and switching of biosimilars in clinical practice. You’ll hear communication tips to address patient and prescriber concerns as well as operational considerations for integrating biosimilars into practice. Special guests: Bharati Bhardwaja, PharmD, BCPS, LSSBBRheumatology Clinical Pharmacy SpecialistKaiser Permanente ColoradoMegan May, PharmD, BCOP, FHOPA, FAPOClinical Oncology Pharmacy Speciali...

People in this episode

Guests: Bharati Bhardwaja, Megan May

Topics covered

• biosimilars
• clinical practice
• patient care
• communication strategies
• pharmacy

Keywords

• biosimilars
• clinical pharmacy
• patient concerns
• prescriber concerns
• drug therapy

Mentioned in this episode

Organizations: Kaiser Permanente Colorado

More episodes of Medication Talk - Expert Insights on Drug Therapy & Patient Care

• GLP-1 Agonists: Clinical Conundrums · April 1, 2026 · 39 min
• Putting Antimicrobial Stewardship Into Practice · March 1, 2026 · 38 min
• BONUS: More Notable New Meds of 2025 · February 19, 2026 · 21 min
• Notable New Meds of 2025 · February 1, 2026 · 35 min
• BONUS: Smoking and Vaping Cessation Conversations · January 22, 2026 · 28 min
• Smoking and Vaping Cessation · January 1, 2026 · 37 min

Explore listener stats, chart rankings, contacts and more on the Medication Talk - Expert Insights on Drug Therapy & Patient Care podcast page.